TR201904913T4 - Esnek yan dolamlar bulunduran antimalaryal bileşimler. - Google Patents
Esnek yan dolamlar bulunduran antimalaryal bileşimler. Download PDFInfo
- Publication number
- TR201904913T4 TR201904913T4 TR2019/04913T TR201904913T TR201904913T4 TR 201904913 T4 TR201904913 T4 TR 201904913T4 TR 2019/04913 T TR2019/04913 T TR 2019/04913T TR 201904913 T TR201904913 T TR 201904913T TR 201904913 T4 TR201904913 T4 TR 201904913T4
- Authority
- TR
- Turkey
- Prior art keywords
- compositions
- loops
- flexible semi
- antimalarial
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000000078 anti-malarial effect Effects 0.000 title abstract 2
- 239000003430 antimalarial agent Substances 0.000 title abstract 2
- 108010022394 Threonine synthase Proteins 0.000 abstract 2
- 102000004419 dihydrofolate reductase Human genes 0.000 abstract 2
- 201000004792 malaria Diseases 0.000 abstract 2
- 241000223960 Plasmodium falciparum Species 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97837507P | 2007-10-08 | 2007-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201904913T4 true TR201904913T4 (tr) | 2019-05-21 |
Family
ID=40534843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/04913T TR201904913T4 (tr) | 2007-10-08 | 2008-10-08 | Esnek yan dolamlar bulunduran antimalaryal bileşimler. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8530491B2 (enExample) |
| EP (2) | EP3546452A1 (enExample) |
| JP (1) | JP5603775B2 (enExample) |
| KR (1) | KR101578949B1 (enExample) |
| CN (1) | CN101820879B (enExample) |
| AU (1) | AU2008310898B2 (enExample) |
| BR (1) | BRPI0818618B8 (enExample) |
| CA (1) | CA2700880C (enExample) |
| CY (1) | CY1121598T1 (enExample) |
| DK (1) | DK2194985T3 (enExample) |
| ES (1) | ES2727015T3 (enExample) |
| HR (1) | HRP20190589T1 (enExample) |
| HU (1) | HUE044398T2 (enExample) |
| LT (1) | LT2194985T (enExample) |
| MX (1) | MX2010003739A (enExample) |
| PL (1) | PL2194985T3 (enExample) |
| PT (1) | PT2194985T (enExample) |
| RU (1) | RU2485107C2 (enExample) |
| SI (1) | SI2194985T1 (enExample) |
| TR (1) | TR201904913T4 (enExample) |
| UA (1) | UA105759C2 (enExample) |
| WO (1) | WO2009048957A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012108845A1 (en) * | 2011-02-09 | 2012-08-16 | National Science And Technology Development Agency | A bacterial surrogate for testing of antimalarials: thya knockout and fola knockout bacteria for testing of inhibition of malarial dihydrofolate reductase-thymidylate synthase |
| US9000003B2 (en) * | 2011-03-10 | 2015-04-07 | National Science And Technology Development Agency | Anti-folate antimalarials with dual-binding modes and their preparation |
| WO2015047199A2 (en) | 2013-09-30 | 2015-04-02 | National Science And Technology Development Agency | A bacterial surrogate for testing of antimalarials: thya knockout, fola knockout, folp knockout, and folk knockout bacteria for testing of inhibition of antifolate pathway |
| CN104593406A (zh) * | 2015-01-08 | 2015-05-06 | 山西医科大学 | pIRES/TgDHFR-TS真核表达重组质粒及其构建和应用 |
| WO2017052479A1 (en) * | 2015-09-23 | 2017-03-30 | National Science And Technology Development Agency | 2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against plasmodium falciparum |
| CN106083742A (zh) * | 2016-05-31 | 2016-11-09 | 广东工业大学 | 一种2,4‑二胺基喹唑啉衍生物及其制备方法和应用 |
| WO2021155748A1 (en) * | 2020-02-04 | 2021-08-12 | Tsinghua University | Inhibitors of malarial and plasmodium falciparum hexose transporter and uses thereof |
| CN112961106A (zh) * | 2021-03-13 | 2021-06-15 | 德州学院 | 一种4-羟基-6氯喹啉合成新工艺 |
| EP4438596A1 (en) * | 2023-03-28 | 2024-10-02 | Université de Lille | Diaminopyrimidine derivatives as hdac and dhfr dual-targeting inhibitors and use thereof in preventing and treating malaria |
| WO2025053796A1 (en) * | 2023-09-04 | 2025-03-13 | National Science And Technology Development Agency | Hybrid molecules between pyrimidine derivatives and idasanutlin |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4033962A (en) * | 1975-06-26 | 1977-07-05 | Hoffman-La Roche Inc. | 2,4-Diamino-pyrimidine derivatives and processes |
| GB1546937A (en) * | 1976-07-29 | 1979-05-31 | Beecham Group Ltd | 2,4-diaminopyrimidine derivatives |
| FR2397407A2 (fr) * | 1977-07-11 | 1979-02-09 | Dick Pierre | Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides |
| OA07362A (fr) * | 1980-10-27 | 1984-06-30 | May & Baker Ltd | Dérivés de la pyrimidine, leur procédé de préparation et les compositions les contenant. |
| GB2086386B (en) | 1980-10-27 | 1984-01-18 | May & Baker Ltd | Pyrimidine derivatives |
| US5322858A (en) | 1992-02-14 | 1994-06-21 | Jacobus Pharmaceutical Co. Inc. | N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines |
| RU95113597A (ru) | 1992-12-02 | 1997-06-10 | ФМК Корпорейшн (US) | Инсектицидная композиция, способы борьбы с насекомыми |
| HK1042049A1 (en) | 1999-05-24 | 2002-08-02 | Sankyo Company, Limited | Medicinal compositions containing anti-fas antibody |
| IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
| US7371758B2 (en) * | 2003-03-13 | 2008-05-13 | National Science & Technology Development Agency | Antimalarial pyrimidine derivatives and methods of making and using them |
-
2008
- 2008-10-08 BR BRPI0818618A patent/BRPI0818618B8/pt active IP Right Grant
- 2008-10-08 HR HRP20190589TT patent/HRP20190589T1/hr unknown
- 2008-10-08 LT LTEP08837766.8T patent/LT2194985T/lt unknown
- 2008-10-08 JP JP2010528223A patent/JP5603775B2/ja active Active
- 2008-10-08 PL PL08837766T patent/PL2194985T3/pl unknown
- 2008-10-08 PT PT08837766T patent/PT2194985T/pt unknown
- 2008-10-08 RU RU2010117193/04A patent/RU2485107C2/ru active
- 2008-10-08 SI SI200832053T patent/SI2194985T1/sl unknown
- 2008-10-08 WO PCT/US2008/079210 patent/WO2009048957A1/en not_active Ceased
- 2008-10-08 AU AU2008310898A patent/AU2008310898B2/en active Active
- 2008-10-08 ES ES08837766T patent/ES2727015T3/es active Active
- 2008-10-08 MX MX2010003739A patent/MX2010003739A/es active IP Right Grant
- 2008-10-08 US US12/247,953 patent/US8530491B2/en active Active
- 2008-10-08 EP EP19157867.3A patent/EP3546452A1/en not_active Withdrawn
- 2008-10-08 DK DK08837766.8T patent/DK2194985T3/da active
- 2008-10-08 HU HUE08837766 patent/HUE044398T2/hu unknown
- 2008-10-08 TR TR2019/04913T patent/TR201904913T4/tr unknown
- 2008-10-08 KR KR1020107010151A patent/KR101578949B1/ko active Active
- 2008-10-08 CA CA2700880A patent/CA2700880C/en active Active
- 2008-10-08 UA UAA201004117A patent/UA105759C2/uk unknown
- 2008-10-08 CN CN2008801106805A patent/CN101820879B/zh active Active
- 2008-10-08 EP EP08837766.8A patent/EP2194985B1/en active Active
-
2019
- 2019-04-19 CY CY20191100432T patent/CY1121598T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201904913T4 (tr) | Esnek yan dolamlar bulunduran antimalaryal bileşimler. | |
| MA32316B1 (fr) | Derives spiro-indoles pour le traitement de maladies parasitaires | |
| EA201391236A1 (ru) | Новые циклические производные азабензимидазола, используемые в качестве антидиабетических агентов | |
| AU2018256602A1 (en) | Functionalized benzamide derivatives as antiviral agents against hbv infection | |
| CY1118362T1 (el) | Ανταγωνιστες υποδοχεων cgrp αζαϊνδανιου καρβοξαμιδιου πιπεριδινονης | |
| CY1118454T1 (el) | Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες | |
| ATE542813T1 (de) | 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren | |
| NO20083726L (no) | Spiroindolinon derivater | |
| CR20120397A (es) | Inhibidores del virus de la hepatitis c | |
| EA201071329A1 (ru) | Диамидные производные адамантана и их применение | |
| BR112014006283A2 (pt) | novos derivados de dihidroquinolina-2-ona | |
| BR112015010221A2 (pt) | inibidores de cinase alk | |
| EA201101194A1 (ru) | Применение розувастатин лактолов в качестве лекарственных препаратов | |
| CL2008002361A1 (es) | Uso de un antigeno derivado de la proteina circumesporozoito (cs) de plasmodium falciparum que se expresa en la etapa preeritrocitica de la infeccion por malaria para tratar bebes contra la malaria. | |
| EP2114442A4 (en) | HAT ACETYLATING PHOTOMOTORS AND USES OF COMPOSITIONS IN PROMOTING IMMUNOGENICITY | |
| CY1117893T1 (el) | Θεραπευτικα σχηματα | |
| CY1113240T1 (el) | Αλατα ενωσεων αναστολεα hiv | |
| UA101556C2 (uk) | Комбіноване застосування інгібітора pde 4 та інгібітора hmg-coa-редуктази для профілактики або зцілювального лікування запального захворювання легенів | |
| EA201290229A1 (ru) | Производные спиролактама и их применение | |
| ECSP11011440A (es) | Combinación antitumoral que comprende ave8062 y sorafenib | |
| ATE513818T1 (de) | Chinazolinonderivate als tubulinpolymerisationshemmer | |
| UA107088C2 (xx) | 5-(3,4-дихлорфеніл)-n-(2-гідроксициклогексил)-6-(2,2,2-трифторетокси)нікотинамід і його солі як засоби, що підвищують концентрацію лвщ холестерину | |
| WO2010047819A8 (en) | Hydroxyethylamino sulfonamide derivatives | |
| WO2010068920A3 (en) | Diaminoquinazoline inhibitors of dihydrofolate reductase | |
| MX2011007897A (es) | Derivados de sulfamoil-fenil-ureido benzamidina como agentes contra la malaria. |